Randy Shaver Cancer Research & Community Fund Awards

February 6, 2019

Each year the Randy Shaver Cancer Research & Community Fund awards grants to groups across the state of Minnesota that are working to reduce the burden of cancer. 

The mission of the Randy Shaver Cancer Research and Community Fund is to support the cancer community in Minnesota by funding research, prevention, treatment and other programs relating to the cancer community’s needs.

The following Masonic Cancer Center members were recently awarded Shaver Fund Awards from the Randy Shaver Cancer Research and Community Fund.

Jeffrey Albrecht, MDIdentify Novel Genes That Could Be Targeted in Liver Cancer (Working with Patients at the VA)
Martina Bazzaro, PhDTesting and Gene Expression Profiling to Detect Chemoresistat Endometrial Cancer
Julia Davydova, MD, PhDDevelop New Imaging and Multimodal Interventions for Pancreatic Cancer to Facilitate Accurate Diagnosis and Improved Therapy
Mark Klein, MDIdentify Strategies to Enhance Immunotherapy Against Mesothelioma Via Lab-Based Methods (Working with Patients at the VA)
Badrinath Konety, MD, MBA and Jayanth Panyam, PhDNew Treatment for Bladder Cancer
Betsy Kren, PhDInvestigate Therapy As A Potential Treatment for Patients with Localized or Metastatic Liver Cancer
Emil Lou, MD, PhD, FACPExamine the Ability of Alternating Electric Fields to Disrupt Intercellular Communication
Walter Low, PhDZika Virus – Based Therapy for Treating Malignant Brain Tumors
Branden Moriarity, PhDDevelop A Novel Antibody based Therapeutic with Intent of Eventual Clinical Translation for Pediatric Osteosarcoma
Michael Olin, PhDDetermine Efficacy of CD200 Inhibitor in Phase I Clinical Trial for Glioblastoma
Christopher Pennell, PhDUnderstanding Neurotoxicity in A Mouse Model of Cancer Immunotherapy for Leukemias and Lymphomas
David Potter, MD, PhD - Overcoming Hormone Therapy Resistance in ER+ and HER2- Breast Cancer
Paolo Provenzano, PhDEngineering Novel Cell-Based Therapies to Combat Pancreatic Cancer
Arpit Rao, MBBSPerform Translational and Clinical Investigation of CDK4/6 inhibitor Therapies in Patients with Advanced Prostate Cancer
Deepali Sachdev, PhDTest A Novel Immunotherapy for Solid Cancers (Metastatic Breast Cancer & Prostate Cancer)
Timothy Starr, PhDDevelop Immunotherapy for Treating Advanced Ovarian Cancer
Daniel Vallera, PhDTaking Next Steps Toward Bringing New Immunotherapy Drug to First in Human Trials (Leukemia)